Skip to main content
SpringerLink
Log in

Therapie von vaskulären Hochrisikopatienten: Telmisartan, Ramipril oder eine Kombination?

Therapy of patients at high risk for vascular events, Telmisartan, ramipril or a combination?

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Dickstein K, Kjekshus J; OPTIMAAL Steering Committee of the OPTIMAAL Study Group (2002) Effect of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Lancet 360: 752–760

    Article  PubMed  CAS  Google Scholar 

  2. Pfeffer MA, McMurray JJV, Velazquez EJ et al. for the Valsartan in Acute Myocardial Infarction Trial Investigators (2003) Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both. N Engl J Med 349: 1893–1906

    Article  PubMed  CAS  Google Scholar 

  3. Pitt B, Poole-Wilson PA, Segal R et al. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial – The Losartan Heart Failure Survival Study ELITE II. Lancet 355: 1582–1587

    Article  PubMed  CAS  Google Scholar 

  4. The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342: 145–153

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin:

Prof. Dr. R. Düsing hat für die Fa. Boehringer Ingelheim honorierte wissenschaftliche Vorträge gehalten.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Wilhelm Straße 35-37, 53111, Bonn, Deutschland

    R. Düsing

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. R. Düsing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Düsing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Düsing, R., Nitschmann, S. Therapie von vaskulären Hochrisikopatienten: Telmisartan, Ramipril oder eine Kombination?. Internist 49, 1137–1140 (2008). https://doi.org/10.1007/s00108-008-2199-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-008-2199-4

Search

Navigation